{"id":28662,"date":"2026-02-20T12:17:15","date_gmt":"2026-02-20T12:17:15","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=28662"},"modified":"2026-02-20T12:17:15","modified_gmt":"2026-02-20T12:17:15","slug":"japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/","title":{"rendered":"\u65e5\u672c\u521d\u306eiPS\u7d30\u80de\u7531\u6765\u6cbb\u7642\u85ac\u3092\u627f\u8a8d\u3001\u518d\u751f\u533b\u7642\u306e\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc\u306b"},"content":{"rendered":"

Japan is at the forefront of healthcare innovation by becoming the first nation to approve two medical treatments derived from induced pluripotent stem (iPS) cells. The expert panel of the health ministry in Japan has approved a significant move forward in the utilization of stem cell science for actual therapies and, therefore, have confirmed the country’s leading position in regenerative medicine.<\/p>

The decision is a testament to Japan’s long, standing commitment to speed up the process of bringing clinical applications of highly innovative biotechnology to the market and, at the same time, it is solidifying its worldwide standing in biomedical research and therapeutic advancement. The treatments, according to the news, are likely to break the ground for new differentials of therapeutic interventions for ameliorating severe conditions through the regeneration of damaged tissues and the restoration of organ functions.<\/p>

\u4f55\u304ciPS\u7d30\u80de\u3092\u5909\u9769\u3059\u308b\u306e\u304b<\/strong><\/h3>

\u4eba\u5de5\u591a\u80fd\u6027\u5e79\u7d30\u80de\u306f\u3001\u6210\u719f\u3057\u305f\u5927\u4eba\u306e\u7d30\u80de\u3092\u3001\u4f53\u5185\u306e\u3055\u307e\u3056\u307e\u306a\u7a2e\u985e\u306e\u7d30\u80de\u306b\u5206\u5316\u3059\u308b\u80fd\u529b\u3092\u6301\u3064\u591a\u80fd\u6027\u72b6\u614b\u306b\u521d\u671f\u5316\u3059\u308b\u30d7\u30ed\u30bb\u30b9\u304b\u3089\u751f\u307e\u308c\u307e\u3059\u3002\u3053\u306e\u753b\u671f\u7684\u306a\u6280\u8853\u3092\u958b\u767a\u3057\u305f\u306e\u306f\u65e5\u672c\u4eba\u7814\u7a76\u8005\u306e\u5c71\u4e2d\u4f38\u5f25\u6c0f\u3067\u3001\u5f7c\u306f\u6210\u719f\u7d30\u80de\u3092\u6c4e\u7528\u6027\u306e\u9ad8\u3044\u5e79\u7d30\u80de\u306b\u5909\u3048\u308b\u65b9\u6cd5\u3092\u89e3\u660e\u3057\u305f\u529f\u7e3e\u306b\u3088\u308a\u30ce\u30fc\u30d9\u30eb\u8cde\u3092\u53d7\u8cde\u3057\u307e\u3057\u305f\u3002.<\/p>

\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a \u697d\u5929\u30e1\u30c7\u30a3\u30ab\u30eb\u3068\u30ed\u30c3\u30c6\u30d0\u30a4\u30aa\u30ed\u30b8\u30af\u30b9\u304c\u6226\u7565\u7684\u88fd\u9020\u63d0\u643a\u3092\u7de0\u7d50\u3057\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30aa\u30f3\u30b3\u30ed\u30b8\u30fc\u30d7\u30ed\u30b0\u30e9\u30e0\u3092\u63a8\u9032<\/a><\/h4>

\u80da\u6027\u5e79\u7d30\u80de\u3060\u3051\u3067\u306a\u304f\u3001iPS\u7d30\u80de\u306f\u76ae\u819a\u3084\u8840\u6db2\u306a\u3069\u306e\u6210\u4f53\u7d44\u7e54\u304b\u3089\u3082\u4f5c\u88fd\u3067\u304d\u308b\u305f\u3081\u3001\u502b\u7406\u7684\u306a\u554f\u984c\u304c\u8efd\u6e1b\u3055\u308c\u3001\u60a3\u8005\u56fa\u6709\u306e\u6cbb\u7642\u3078\u306e\u9069\u5408\u6027\u304c\u9ad8\u307e\u308a\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u7d30\u80de\u306f\u3001\u640d\u50b7\u3057\u305f\u7d44\u7e54\u306e\u4ee3\u7528\u3001\u75be\u60a3\u306e\u30e2\u30c7\u30eb\u3001\u500b\u5225\u5316\u533b\u7642\u74b0\u5883\u306b\u304a\u3051\u308b\u65b0\u85ac\u306e\u8a66\u9a13\u306a\u3069\u306b\u5229\u7528\u3067\u304d\u308b\u305f\u3081\u3001\u975e\u5e38\u306b\u4fa1\u5024\u304c\u3042\u308a\u307e\u3059\u3002.<\/p>

\u7814\u7a76\u5ba4\u304b\u3089\u81e8\u5e8a\u3078<\/strong><\/h3>

Japan has led the way in iPS cell research for almost 20 years, backing university programs as well as industry partnerships with a goal of quick commercialization. Initial clinical investigations revealed that iPS, derived cells could be used to successfully treat diseases of the eye and heart, thus opening more medical applications. Getting the green light for these two treatments is a step change from the researchers’ trials to therapies regulated cases, thus indicating increasing trust in their safety and efficacy. Besides, the move showcases Japan’s regulatory preparedness to progressively promote nanobiotech innovations while at the same time ensuring a thorough check, up system.<\/p>

\u4e16\u754c\u306e\u30d8\u30eb\u30b9\u30b1\u30a2\u304a\u3088\u3073\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u7523\u696d\u3078\u306e\u5f71\u97ff<\/strong><\/h3>

\u3053\u306e\u627f\u8a8d\u306f\u3001\u4e16\u754c\u306e\u518d\u751f\u533b\u7642\u5e02\u5834\u306b\u3044\u304f\u3064\u304b\u306e\u5f62\u3067\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u3068\u4e88\u60f3\u3055\u308c\u307e\u3059\uff1a<\/p>

    \n
  1. \u5e79\u7d30\u80de\u306e\u5546\u696d\u5316\u304c\u52a0\u901f<\/strong><\/li>\n<\/ol>

    \u304a\u58a8\u4ed8\u304d\u304c\u5f97\u3089\u308c\u308c\u3070\u3001\u4e16\u754c\u4e2d\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306f\u3001\u5e79\u7d30\u80de\u6cbb\u7642\u3001\u7279\u306b\u60a3\u8005\u7531\u6765\u306e\u7d30\u80de\u3092\u7528\u3044\u305f\u5e79\u7d30\u80de\u6cbb\u7642\u306e\u958b\u767a\u306b\u3001\u3088\u308a\u591a\u304f\u306e\u8cc7\u91d1\u3092\u6295\u5165\u3057\u3066\u304f\u308c\u308b\u304b\u3082\u3057\u308c\u307e\u305b\u3093\u3002.<\/p>

      \n
    1. \u500b\u5225\u5316\u533b\u7642\u306e\u53f0\u982d<\/strong><\/li>\n<\/ol>

      With the help of iPS and cell technologies, one can develop treatments that are very well matched to the patient’s genetics and thus can result in better outcomes and fewer side effects.<\/p>

        \n
      1. \u5b98\u6c11\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u306e\u5f37\u5316<\/strong><\/li>\n<\/ol>

        Japan’s case highlights a well, coordinated cooperation between the universities, government, and pharmaceutical companies, and this is the model that is presently considered essential for the successful development of complex biomedical innovations.<\/p>

          \n
        1. \u533b\u7642\u6280\u8853\u9769\u65b0\u306e\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc\u304c\u3082\u305f\u3089\u3059\u7af6\u4e89\u529b<\/strong><\/li>\n<\/ol>

          \u3053\u306e\u6210\u679c\u306f\u3001\u65e5\u672c\u304c\u56fd\u5185\u306e\u307f\u306a\u3089\u305a\u3001\u56fd\u969b\u7684\u306b\u3082\u518d\u751f\u533b\u7642\u7814\u7a76\u306e\u4e3b\u8981\u62e0\u70b9\u3068\u306a\u308a\u3001\u6d77\u5916\u304b\u3089\u306e\u63d0\u643a\u3084\u8cc7\u91d1\u63d0\u4f9b\u3001\u81e8\u5e8a\u8a66\u9a13\u3092\u8a98\u81f4\u3059\u308b\u80cc\u666f\u3068\u306a\u3063\u3066\u3044\u308b\u306e\u304b\u3082\u3057\u308c\u307e\u305b\u3093\u3002.<\/p>

          \u518d\u751f\u6cbb\u7642\u306e\u5c06\u6765\u5c55\u671b<\/strong><\/h3>

          \u4eca\u56de\u306e\u627f\u8a8d\u306f\u5927\u304d\u306a\u524d\u9032\u3067\u3059\u304c\u3001\u5c02\u9580\u5bb6\u305f\u3061\u306f\u3001\u5927\u91cf\u5c0e\u5165\u306e\u6761\u4ef6\u3068\u306a\u308b\u306e\u306f\u3001\u7523\u696d\u754c\u304c\u88fd\u9020\u898f\u6a21\u3092\u62e1\u5927\u3059\u308b\u80fd\u529b\u3001\u9577\u671f\u7684\u306a\u5b89\u5168\u6027\u306e\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3001\u52b9\u7387\u7684\u306a\u88fd\u9020\u30d7\u30ed\u30bb\u30b9\u306e\u78ba\u7acb\u3067\u3042\u308b\u3068\u6307\u6458\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u6cbb\u7642\u6cd5\u304c\u60a3\u8005\u306b\u6c38\u7d9a\u7684\u306a\u5229\u76ca\u3092\u3082\u305f\u3089\u3059\u3053\u3068\u3092\u4fdd\u8a3c\u3059\u308b\u305f\u3081\u306b\u306f\u3001\u81e8\u5e8a\u7814\u7a76\u3092\u9032\u3081\u308b\u3053\u3068\u304c\u975e\u5e38\u306b\u91cd\u8981\u3067\u3059\u3002.<\/p>

          \u4e00\u65b9\u3001\u3053\u306e\u5224\u6c7a\u306f\u518d\u751f\u533b\u7642\u306e\u9032\u6b69\u3092\u6d6e\u304d\u5f6b\u308a\u306b\u3057\u3001\u5e79\u7d30\u80de\u306b\u57fa\u3065\u304f\u6cbb\u7642\u304c\u8fd1\u3044\u5c06\u6765\u3001\u72ec\u5360\u7684\u306a\u5730\u4f4d\u3092\u8131\u3057\u3066\u4e00\u822c\u306e\u533b\u7642\u5e02\u5834\u306b\u53c2\u5165\u3059\u308b\u53ef\u80fd\u6027\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002.<\/p>","protected":false},"excerpt":{"rendered":"

          Japan is at the forefront of healthcare innovation by becoming the first nation to approve two medical treatments derived from induced pluripotent stem (iPS) cells. The expert panel of the health ministry in Japan has approved a significant move forward in the utilization of stem cell science for actual therapies and, therefore, have confirmed the country’s leading position in regenerative medicine.The decision is a testament to Japan’s long, standing commitment to speed up the process of bringing clinical applications of highly innovative biotechnology to the market and, at the same time, it is solidifying its worldwide standing in biomedical research and therapeutic advancement. The treatments, according to the news, are […]<\/p>\n","protected":false},"author":7,"featured_media":28663,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[89,8098,182],"tags":[150,11558,314,424,592],"ppma_author":[572],"class_list":["post-28662","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-tech","category-news-articles","category-pharma","tag-biotech","tag-ips-cells","tag-japan","tag-pharma","tag-regenerative-medicine"],"yoast_head":"\nJapan Authorizes First iPS Cell-Derived Therapies<\/title>\n<meta name=\"description\" content=\"Japan becomes the first country to approve two iPS cell-based therapies, cementing its leadership in stem cell innovation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Japan Authorizes First iPS Cell-Derived Therapies\" \/>\n<meta property=\"og:description\" content=\"Japan becomes the first country to approve two iPS cell-based therapies, cementing its leadership in stem cell innovation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-20T12:17:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/02\/Japan-becomes-first-to-authorize-2-drugs-developed-from-iPS-cells-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u65e5\u672c\u521d\u306eiPS\u7d30\u80de\u7531\u6765\u6cbb\u7642\u85ac\u3092\u627f\u8a8d","description":"\u65e5\u672c\u304ciPS\u7d30\u80de\u3092\u7528\u3044\u305f2\u3064\u306e\u6cbb\u7642\u6cd5\u3092\u627f\u8a8d\u3057\u305f\u6700\u521d\u306e\u56fd\u306b\u306a\u308a\u3001\u5e79\u7d30\u80de\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306b\u304a\u3051\u308b\u65e5\u672c\u306e\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u304c\u78ba\u56fa\u305f\u308b\u3082\u306e\u306b\u306a\u308a\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/","og_locale":"ja_JP","og_type":"article","og_title":"Japan Authorizes First iPS Cell-Derived Therapies","og_description":"Japan becomes the first country to approve two iPS cell-based therapies, cementing its leadership in stem cell innovation.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/","og_site_name":"itbusinesstoday","article_published_time":"2026-02-20T12:17:15+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/02\/Japan-becomes-first-to-authorize-2-drugs-developed-from-iPS-cells-1.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"4\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Japan Authorizes First iPS Cell-Derived Therapies, Marking Breakthrough in Regenerative Medicine","datePublished":"2026-02-20T12:17:15+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/"},"wordCount":686,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/02\/Japan-becomes-first-to-authorize-2-drugs-developed-from-iPS-cells-1.webp","keywords":["Biotech","iPS cells","Japan","Pharma","regenerative medicine"],"articleSection":["Health Tech","News Articles","Pharma"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/","name":"\u65e5\u672c\u521d\u306eiPS\u7d30\u80de\u7531\u6765\u6cbb\u7642\u85ac\u3092\u627f\u8a8d","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/02\/Japan-becomes-first-to-authorize-2-drugs-developed-from-iPS-cells-1.webp","datePublished":"2026-02-20T12:17:15+00:00","description":"\u65e5\u672c\u304ciPS\u7d30\u80de\u3092\u7528\u3044\u305f2\u3064\u306e\u6cbb\u7642\u6cd5\u3092\u627f\u8a8d\u3057\u305f\u6700\u521d\u306e\u56fd\u306b\u306a\u308a\u3001\u5e79\u7d30\u80de\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306b\u304a\u3051\u308b\u65e5\u672c\u306e\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u304c\u78ba\u56fa\u305f\u308b\u3082\u306e\u306b\u306a\u308a\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/02\/Japan-becomes-first-to-authorize-2-drugs-developed-from-iPS-cells-1.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/02\/Japan-becomes-first-to-authorize-2-drugs-developed-from-iPS-cells-1.webp","width":1200,"height":800,"caption":"Japan"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/pharma\/japan-authorizes-first-ips-cell-derived-therapies-marking-breakthrough-in-regenerative-medicine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Japan Authorizes First iPS Cell-Derived Therapies, Marking Breakthrough in Regenerative Medicine"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"author_category":"","first_name":"ITBT","last_name":"StaffWriter","user_url":"https:\/\/itbusinesstoday.com\/","job_title":"","description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002"}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/28662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=28662"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/28662\/revisions"}],"predecessor-version":[{"id":28664,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/28662\/revisions\/28664"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/28663"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=28662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=28662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=28662"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=28662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}